News | May 02, 2026
Bayer pushes stroke prevention drug forward in China as regulators accept key filing
Stroke is the second-leading cause of death and the third-leading cause of disability worldwide
Stroke is the second-leading cause of death and the third-leading cause of disability worldwide
The company posted revenue of €1,267 million, up 6% on a constant currency basis
The microbiology unit generated $645 million in revenue in 2025 and sits within Thermo Fisher’s Specialty Diagnostics segment
His appointment is expected to further strengthen the company’s financial governance and regional operational strategy across South Asia
The George Institute India’s large-scale community-based model demonstrates reduced depression, self-harm, and suicide risk among adolescents in Delhi and Vijayawada
Reshaped by COVID-19, rising test demand, and a shift toward decentralized diagnostics, qPCR has evolved from niche academic use to a core clinical engine
The summit will bring together 1,200+ delegates, 100+ international faculty from 25 countries
Gambhir brings over 35 years of rich experience in strategic finance, governance, business transformation, and leadership
Two-day long National Health Summit highlighted progress under the NHM and called for data-driven and SDG-aligned health system reforms
Market authorization for generic GLP-1 therapy strengthens company’s diabetes portfolio in Canada
Subscribe To Our Newsletter & Stay Updated
